FY2026 EPS Estimates for Centene Decreased by Zacks Research

Centene Co. (NYSE:CNC) – Equities research analysts at Zacks Research dropped their FY2026 earnings estimates for shares of Centene in a report issued on Tuesday, June 10th. Zacks Research analyst K. Dey now expects that the company will post earnings per share of $7.58 for the year, down from their prior estimate of $7.60. The consensus estimate for Centene’s current full-year earnings is $6.86 per share. Zacks Research also issued estimates for Centene’s Q1 2027 earnings at $3.26 EPS.

Centene (NYSE:CNC) last announced its quarterly earnings results on Friday, April 25th. The company reported $2.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.52 by $0.38. Centene had a net margin of 2.03% and a return on equity of 13.85%. The firm had revenue of $46.62 billion during the quarter, compared to the consensus estimate of $43.16 billion. During the same period last year, the firm posted $2.26 EPS. The firm’s quarterly revenue was up 15.4% on a year-over-year basis.

Other equities analysts also recently issued reports about the stock. Barclays reissued an “equal weight” rating and set a $65.00 price target (down from $84.00) on shares of Centene in a report on Monday, June 2nd. Wells Fargo & Company lowered their price objective on shares of Centene from $76.00 to $72.00 and set an “overweight” rating for the company in a research report on Friday, February 14th. Jefferies Financial Group lowered their price objective on shares of Centene from $64.00 to $61.00 and set a “hold” rating for the company in a research report on Tuesday, April 29th. Robert W. Baird lowered their price objective on shares of Centene from $71.00 to $69.00 and set a “neutral” rating for the company in a research report on Tuesday, April 15th. Finally, Guggenheim restated a “neutral” rating on shares of Centene in a research report on Tuesday, April 29th. Seven equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $77.71.

Centene Trading Down 0.3%

Shares of CNC stock opened at $55.20 on Friday. Centene has a 12-month low of $54.01 and a 12-month high of $80.59. The company has a market capitalization of $27.47 billion, a P/E ratio of 8.85, a P/E/G ratio of 0.80 and a beta of 0.45. The firm has a 50-day moving average price of $59.29 and a 200 day moving average price of $59.92. The company has a quick ratio of 1.10, a current ratio of 1.11 and a debt-to-equity ratio of 0.70.

Institutional Investors Weigh In On Centene

Several institutional investors have recently modified their holdings of CNC. Capital Advisors Ltd. LLC grew its position in shares of Centene by 75.3% during the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock worth $25,000 after buying an additional 177 shares during the period. Pinney & Scofield Inc. acquired a new stake in shares of Centene during the 4th quarter worth approximately $25,000. Hurley Capital LLC bought a new position in Centene during the 4th quarter worth approximately $26,000. Ameriflex Group Inc. bought a new position in Centene during the 4th quarter worth approximately $26,000. Finally, Quarry LP bought a new position in Centene during the 1st quarter worth approximately $26,000. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.